In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, Eris Lifesciences has informed about Analyst/ Institutional Investor Meeting on Wednesday, January 04, 2023.
The above information is a part of company’s filings submitted to BSE.